UBS Adjusts Price Target and Estimates on Bruker (BRKR); Possible Upside Opportunity for Patient Investors

August 1, 2012 11:43 AM EDT Send to a Friend
Get Alerts BRKR Hot Sheet
Price: $16.82 +0.18%

Rating Summary:
    12 Buy, 4 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 12 | Down: 19 | New: 21
Trade BRKR Now!
UBS maintains a 'Buy' on Bruker (NASDAQ: BRKR) price target of $14.00 (from $19.00).

Analyst, Daniel Arias, said, "While 2Q represents a clear step backwards (and a shot to credibility), we remain bullish on BRKR’s relative sales growth profile & think true margin expansion can be attained once the pieces are in place. Furthermore, a fresh set of eyes on the business (Charlie Wagner became CFO in June) is encouraging. That said, end markets remain challenging and improvements will likely take time, making the stock an investment best suited for those with longer-term horizons and patience."

FY12 EPS estimate lowered from $0.97 to $0.66 and FY13 from $1.13 to $0.84.

For an analyst ratings summary and ratings history on Bruker click here. For more ratings news on Bruker click here.

Shares of Bruker closed at $11.82 yesterday, with a 52 week range of $9.91-$17.54.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

UBS

Add Your Comment